Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2017 April;108(2) > Minerva Medica 2017 April;108(2):191-3

CURRENT ISSUE
 

ARTICLE TOOLS

Publication history
Reprints
Cite this article as

MINERVA MEDICA

A Journal on Internal Medicine


Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,878


eTOC

 

LETTERS TO THE EDITOR  


Minerva Medica 2017 April;108(2):191-3

DOI: 10.23736/S0026-4806.16.04850-3

Copyright © 2016 EDIZIONI MINERVA MEDICA

language: English

Knockdown of ZEB1 suppresses the formation of vasculogenic mimicry in breast cancer cell line MDA-MB-231 through downregulation of Flk-1

Huiying LI 1, Shasha SONG 2, Yintao XU 3, Jia ZHAO 4, Huantao LIU 4

1 Department of Anesthesiology, Second Hospital, Shandong University, Jinan, China; 2 Department of Pathology, Jinan Central Hospital, Jinan, China; 3 Department of Gynecology and Obstetrics, Qilu Hospital, Shandong University, Jinan, China; 4 Department of Breast Surgery, Qilu Hospital, Shandong University, Jinan, China


PDF  


top of page

Publication History

Issue published online: February 20, 2017
Manuscript accepted: November 17, 2016
Manuscript revised: November 11, 2016
Manuscript received: October 1, 2016

Cite this article as

Li H, Song S, Xu Y, Zhao J, Liu H. Knockdown of ZEB1 suppresses the formation of vasculogenic mimicry in breast cancer cell line MDA-MB-231 through down regulation of flk-1. Minerva Med 2017;108:191-3. DOI: 10.23736/S0026-4806.16.04850-3

Corresponding author e-mail

lr9413@163.com